Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fructooligosaccharide (FOS) is a naturally occurring oligosaccharide composed of short chains of fructose molecules with a terminal glucose unit. It is found in various plants such as onion, chicory, garlic, asparagus, banana, and artichoke. FOS is not digested by human enzymes in the small intestine; instead it reaches the colon intact where it serves as a prebiotic—feeding beneficial gut bacteria like Bifidobacteria. Its fermentation produces short-chain fatty acids that support gut health and may improve mineral absorption[3][7][8]. FOS has been associated with several physiological benefits including improved bowel regularity (relief from constipation), reduced blood sugar spikes due to its indigestibility and low caloric value, potential cholesterol-löwering effects, enhanced mineral absorption (notably calcium), and possible immune modulation[1][2][3][5]. It is widely used as a dietary fiber supplement and alternative sweetener in food products due to its mild sweetness (30–50% that of sucrose) and non-cariogenic properties[10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fructooligosaccharide.